This is our space.
Let us help you find yours.

Phone: 417.890.9728 Email: contact@themedpack.com
1200 E. Woodhurst, Building L-100, Springfield, Missouri 65804
OUR OFFICE - creative work in progress
CONTACT US
SEND THIS FORM
The Medical News
Four Democratic leaders on the U.S. House of Representatives Energy and Commerce committee on Monday wrote Alphabet Inc's Google and Ascension Health demanding briefings by Dec. 6 on how patient data the hospital chain is storing on the cloud is used.... The state of California on Monday sued e-cigarette maker Juul Labs Inc, alleging the San Francisco company engaged in a "systematic" and "wildly successful" campaign to attract teenagers to its nicotine devices.... (Reuters Health) - Telling the difference between a teen's normal ups and downs and something bigger is among top challenges parents face in identifying youth depression, a new national poll suggests.... (Reuters Health) - States that expand public health benefits to cover low-income legal immigrants don't appear to experience a surge in immigrants moving to get medical coverage, a U.S. study suggests.... (Reuters Health) - With several small studies suggesting that the widely prescribed cholesterol-lowering drugs, statins, might be linked to memory loss in seniors, patients were understandably concerned. But a large new study finds no link between memory loss and the drugs.... (Reuters Health) - The inflammation-fighting drug colchicine, already a treatment for gout, dramatically reduces the odds of future cardiovascular problems in people who have just survived a heart attack, a large new study has concluded.... Portugal's Champalimaud Foundation announced on Monday the world's largest annual prize, worth 1 million euros, for research and clinical practices aiming to control or eradicate cancer.... German biotech company Morphosys said more patients would be recruited for a study testing its most advanced drug against a common type of blood cancer, following an encouraging interim data readout.... Novartis is exiting drug discovery at its Shanghai site and shifting its focus to drug development, saying accelerating approvals in China are pushing the Swiss company to dedicate the operation's resources to getting its medicines to market.... Some people who had been in close contact with pneumonic plague patients from Inner Mongolia have been released from medical observation, China's health authority said on Monday.... Merck & Co Inc <MRK.N said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study.... The Indian government has told a court that its federal ban on the sale of electronic cigarettes implies that their use is also prohibited, legal documents seen by Reuters showed, in a further clampdown on the devices.... China's Inner Mongolia reported a fresh, confirmed case of bubonic plague on Sunday, despite an earlier declaration by the country's health officials that the risk of an outbreak was minimal.... China reported a third case of bubonic plague on Sunday after two other plague cases were revealed last week, but the disease remains rare despite its fearsome reputation and authorities say the cases appear unrelated.... China's agriculture ministry said on Monday it will launch an investigation into the illegal production, sale and use of African swine fever vaccines in the country, citing online reports of their use by some farmers.... Samoa declared a state of emergency this weekend, closing all schools and cracking down on public gatherings, after several deaths linked to a measles outbreak that has spread across the Pacific islands.... Many patients with severe but stable heart disease who routinely undergo invasive procedures to clear and prop open clogged arteries would do as well by just taking medications and making lifestyle changes, U.S. researchers reported on Saturday.... (The Nov 16 story corrects to clarify in second graph that patients will be infused by a healthcare provider.)... An Oklahoma judge on Friday said Johnson & Johnson must pay that state $465 million for fueling the opioid epidemic through the deceptive marketing of painkillers, down from his original award of $572 million.... China-based drugmaker BeiGene Ltd on Friday priced its drug, Brukinsa, to treat a rare form of lymphoma at $12,935 for a 30-day supply....